Exploring the Mechanism of Adjuvant Treatment of Glioblastoma Using Temozolomide and Metformin

Glioblastoma is the most frequent and lethal primary central nervous system tumor in adults, accounting for around 15% of intracranial neoplasms and 40–50% of all primary malignant brain tumors, with an annual incidence of 3–6 cases per 100,000 population. Despite maximum treatment, patients only ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Shao-Wei, Chang, Pei-Chi, Chen, Hsuan-Yu, Hueng, Dueng-Yuan, Li, Yao-Feng, Huang, Shih-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330793/
https://www.ncbi.nlm.nih.gov/pubmed/35897747
http://dx.doi.org/10.3390/ijms23158171

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330793/
https://www.ncbi.nlm.nih.gov/pubmed/35897747
http://dx.doi.org/10.3390/ijms23158171

Ejemplares similares